An Open-Label, Single Sequence Study to Assess the Effect of a Single Dose of Cyclosporine on the Steady-State Pharmacokinetics of JNJ-28431754 (Canagliflozin) in Healthy Adult Subjects

Trial Profile

An Open-Label, Single Sequence Study to Assess the Effect of a Single Dose of Cyclosporine on the Steady-State Pharmacokinetics of JNJ-28431754 (Canagliflozin) in Healthy Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Jun 2013

At a glance

  • Drugs Canagliflozin (Primary) ; Ciclosporin
  • Indications Obesity; Psoriasis; Rheumatoid arthritis; Transplant rejection; Type 2 diabetes mellitus; Ulcerative colitis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 23 Nov 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top